Frank Li is the founder and CEO of Stately Bio, a biotechnology company established in 2022 that leverages machine learning for regenerative medicine. Before founding Stately Bio, Li led the machine learning group at Calico Life Sciences, an Alphabet-backed biotech firm focused on aging and longevity. His background also includes roles as a software engineer at Palantir and Google X.

Li's transition from technology to biotechnology was marked by his realization of the potential for computer vision techniques, commonly used in fields like self-driving cars, to analyse biological data. This insight led him to explore the application of machine learning to cell imaging, culminating in the founding of Stately Bio.